164 related articles for article (PubMed ID: 24598749)
21. Crystallization and preliminary neutron diffraction experiment of human farnesyl pyrophosphate synthase complexed with risedronate.
Yokoyama T; Ostermann A; Mizuguchi M; Niimura N; Schrader TE; Tanaka I
Acta Crystallogr F Struct Biol Commun; 2014 Apr; 70(Pt 4):470-2. PubMed ID: 24699741
[TBL] [Abstract][Full Text] [Related]
22. Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.
Stresing V; Fournier PG; Bellahcène A; Benzaïd I; Mönkkönen H; Colombel M; Ebetino FH; Castronovo V; Clézardin P
Bone; 2011 Feb; 48(2):259-66. PubMed ID: 20920623
[TBL] [Abstract][Full Text] [Related]
23. Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation.
Zhang Y; Cao R; Yin F; Hudock MP; Guo RT; Krysiak K; Mukherjee S; Gao YG; Robinson H; Song Y; No JH; Bergan K; Leon A; Cass L; Goddard A; Chang TK; Lin FY; Van Beek E; Papapoulos S; Wang AH; Kubo T; Ochi M; Mukkamala D; Oldfield E
J Am Chem Soc; 2009 Apr; 131(14):5153-62. PubMed ID: 19309137
[TBL] [Abstract][Full Text] [Related]
24. Targeting isoprenoid biosynthesis for drug discovery: bench to bedside.
Oldfield E
Acc Chem Res; 2010 Sep; 43(9):1216-26. PubMed ID: 20560544
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
Dunford JE; Thompson K; Coxon FP; Luckman SP; Hahn FM; Poulter CD; Ebetino FH; Rogers MJ
J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603
[TBL] [Abstract][Full Text] [Related]
26. Farnesyl pyrophosphate synthase modulators: a patent review (2006 - 2010).
Sun S; McKenna CE
Expert Opin Ther Pat; 2011 Sep; 21(9):1433-51. PubMed ID: 21702715
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, calorimetry, and crystallographic analysis of 2-alkylaminoethyl-1,1-bisphosphonates as inhibitors of Trypanosoma cruzi farnesyl diphosphate synthase.
Aripirala S; Szajnman SH; Jakoncic J; Rodriguez JB; Docampo R; Gabelli SB; Amzel LM
J Med Chem; 2012 Jul; 55(14):6445-54. PubMed ID: 22715997
[TBL] [Abstract][Full Text] [Related]
28. Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.
Sanders JM; Ghosh S; Chan JM; Meints G; Wang H; Raker AM; Song Y; Colantino A; Burzynska A; Kafarski P; Morita CT; Oldfield E
J Med Chem; 2004 Jan; 47(2):375-84. PubMed ID: 14711309
[TBL] [Abstract][Full Text] [Related]
29. Human farnesyl pyrophosphate synthase inhibition by nitrogen bisphosphonates: a 3D-QSAR study.
Fernández D; Ortega-Castro J; Frau J
J Comput Aided Mol Des; 2013 Aug; 27(8):739-54. PubMed ID: 23979193
[TBL] [Abstract][Full Text] [Related]
30. Thienopyrimidine bisphosphonate (ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: optimization and characterization of the mode of inhibition.
Leung CY; Park J; De Schutter JW; Sebag M; Berghuis AM; Tsantrizos YS
J Med Chem; 2013 Oct; 56(20):7939-50. PubMed ID: 23998921
[TBL] [Abstract][Full Text] [Related]
31. Crystallographic and thermodynamic characterization of phenylaminopyridine bisphosphonates binding to human farnesyl pyrophosphate synthase.
Park J; Rodionov D; De Schutter JW; Lin YS; Tsantrizos YS; Berghuis AM
PLoS One; 2017; 12(10):e0186447. PubMed ID: 29036218
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the catalytic mechanism of farnesyl pyrophosphate synthase by computer simulation.
Sanchez VM; Crespo A; Gutkind JS; Turjanski AG
J Phys Chem B; 2006 Sep; 110(36):18052-7. PubMed ID: 16956297
[TBL] [Abstract][Full Text] [Related]
33. Bisphosphonates: the first 40 years.
Russell RG
Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
[TBL] [Abstract][Full Text] [Related]
34. Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid.
Idrees AS; Sugie T; Inoue C; Murata-Hirai K; Okamura H; Morita CT; Minato N; Toi M; Tanaka Y
Cancer Sci; 2013 May; 104(5):536-42. PubMed ID: 23387443
[TBL] [Abstract][Full Text] [Related]
35. Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.
Jahnke W; Rondeau JM; Cotesta S; Marzinzik A; Pellé X; Geiser M; Strauss A; Götte M; Bitsch F; Hemmig R; Henry C; Lehmann S; Glickman JF; Roddy TP; Stout SJ; Green JR
Nat Chem Biol; 2010 Sep; 6(9):660-6. PubMed ID: 20711197
[TBL] [Abstract][Full Text] [Related]
36. Pharmacophore modeling, docking and molecular dynamics to identify Leishmania major farnesyl pyrophosphate synthase inhibitors.
de Mattos Oliveira L; Araújo JSC; Bacelar Costa Junior D; Santana IB; Duarte AA; Leite FHA; Benevides RG; Coelho Dos Santos Junior M
J Mol Model; 2018 Oct; 24(11):314. PubMed ID: 30327889
[TBL] [Abstract][Full Text] [Related]
37. Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells.
Räikkönen J; Taskinen M; Dunford JE; Mönkkönen H; Auriola S; Mönkkönen J
Biochem Biophys Res Commun; 2011 Apr; 407(4):663-7. PubMed ID: 21420384
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of endogenous farnesyl diphosphate synthase overcomes the inhibitory effect of bisphosphonate on protein prenylation in Hela cells.
Das S; Edwards PA; Crockett JC; Rogers MJ
Biochim Biophys Acta; 2014 Apr; 1841(4):569-73. PubMed ID: 24369118
[TBL] [Abstract][Full Text] [Related]
39. Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase.
Gritzalis D; Park J; Chiu W; Cho H; Lin YS; De Schutter JW; Lacbay CM; Zielinski M; Berghuis AM; Tsantrizos YS
Bioorg Med Chem Lett; 2015 Mar; 25(5):1117-23. PubMed ID: 25630225
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the N-BP Binding at FPPS by Combined Computational Approaches.
Stefanucci A; Marrone A; Agamennone M
Med Chem; 2015; 11(5):417-31. PubMed ID: 25541745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
